Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23315)

• Formulation Name: Triclabendazole 250 mg tablet
• Company: Novartis Pharmaceuticals Corporation

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
TRICLABENDAZOLE	(DMPWGBR)	Helminth infection	1F90.0	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Haematite red	(E00236)	14833	Colorant
Hydrophobic colloidal silica	(E00285)	24261	Anticaking agent; Emulsion stabilizing agent; Glidant; Suspending agent; Viscosity-controlling agent
Lactose monohydrate	(E00393)	104938	Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate	(E00208)	11177	lubricant
Methylhydroxyethylcellulose	(E00703)	Not Available	Coating agent; Emulsion stabilizing agent; Modified-release agent; Suspending agent; Binding agent; Viscosity-controlling agent
Pregelatinized starch	(E00674)	Not Available	Binding agent; Diluent; Disintegrant